The improved survival of hematopoietic cells cultured with a fusion protein of insulin-like growth factor II (IGF-II) and interleukin 3 (IL-3) is associated with increases in Bcl-xL and phosphatidylinositol-3 kinase activity

Journal of Leukocyte Biology

Volumn 73, Issue 2, 2003, Pages 297-305

  DiFalco, Marcos R ^a,b   Ali, Suhad ^a,b   Congote, Luis Fernando ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

CD34; Stat5

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; HYBRID PROTEIN; INTERLEUKIN 3; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROPIDIUM IODIDE; PROTEIN BCL XL; RECOMBINANT PROTEIN; SOMATOMEDIN B; STAT5 PROTEIN;

APOPTOSIS; ARTICLE; CELL CYCLE S PHASE; CELL SURVIVAL; CHIMERA; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FLUORESCENCE ACTIVATED CELL SORTING; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UMBILICAL CORD;

1-PHOSPHATIDYLINOSITOL 3-KINASE; BCL-X PROTEIN; CELL CYCLE; CELL SURVIVAL; CELLS, CULTURED; HEMATOPOIETIC STEM CELLS; HUMANS; INSULIN-LIKE GROWTH FACTOR II; INTERLEUKIN-3; PROTO-ONCOGENE PROTEINS C-BCL-2; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION;

EID: 0037310077     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0802396     Document Type: Article

References (41)

1. Lowry, P. A. (1995) Hematopoietic stem cell cytokine response. J. Cell. Biochem. 58, 410-415.
2. Congote, L. F., Li, Q. (1994) Accurate processing and secretion in the baculovirus expression system of an erythroid-cell-stimulating factor consisting of a chimaera of insulin-like growth factor II and an insect insulin-like peptide. Biochem. J. 299, 101-107.
3. DiFalco, M. R., Congote, L. F. (1997) Preparation of a recombinant chimera of insulin-like growth factor II and interleukin 3 with high proliferative potency for hematopoietic cells. Biochem. J. 326, 407-413.
4. Peruzzi, F., Prisco, M., Dews, M., Salomoni, P., Grassilli, E., Romano, G., Calabretta, B., Baserga, R. (1999) Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol. Cell. Biol. 19, 7203-7215.
5. Muta, K., Krantz, S. B. (1993) Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin. J. Cell. Physiol. 156, 264-271.
6. Brandt, J. E., Bhalla, K., Hoffman, R. (1994) Effects of interleukin-3 and c-kit ligand on the survival of various classes of human hematopoietic progenitor cells. Blood 83, 1507-1514.
7. Baffy, G., Miyashita, T., Williamson, J. R., Reed, J. C. (1993) Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforoed Bcl-2 oncoprotein production. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line. J. Biol. Chem. 268, 6511-6519.
8. Dumon, S., Santos, S.C., Debierre-Grockiego, F., Gouilleux-Gruart, V., Cocault, L., Boucheron, C., Mollat, P., Gisselbrecht, S., Gouilleux, F. (1999) IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line. Oncogene 18, 4191-4199.
9. Minshall, C., Arkins, S., Freund, G. G., Kelley, K. W. (1996) Requirement for phosphatidylinositol 3′-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor. J. Immunol. 156, 939-947.
10. Parrizas, M., LeRoith, D. (1997) Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-xL gene product. Endocrinology 138, 1355-1358.
11. DiFalco, M. R., Congote, L. F. (2002) Antagonism between interleukin 3 and erythropoietin in mice with azidothymidine-induced anemia and in bone marrow endothelial cells. Cytokine 18, 51-60.
12. Chughtai, N., Schimchowitsch, S., Lebrun, J. J., Ali, S. (2002) Prolactin induces SHP-2 association with Stat5, nuclear translocation, and binding to the beta-casein gene promoter in mammary cells. J. Biol. Chem. 277, 31107-31114.
13. Curtis, H., Sandoval, C., Oblin, C., Difalco, M. R., Congote, L. F. (2002) Insect cell production of a secreted form of human alpha(1)-proteinase inhibitor as a bifunctional protein which inhibits neutrophil elastase and has growth factor-like activities. J. Biotechnol. 93, 35-44.
14. Royal, I., Park, M. (1995) Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3-kinase. J. Biol. Chem. 270, 27780-27787.
15. Wang, L. M., Michieli, P., Lie, W. R., Liu, F., Lee, C. C., Minty, A., Sun, X. J., Levine, A., White, M. F., Pierce, J. H. (1995) The insulin receptor substrate-1-related 4PS substrate but not the interleukin-2R gamma chain is involved in interleukin-13-mediated signal transduction. Blood 86, 4218-4227.
16. Okajima, Y., Matsumura, I., Nishiura, T., Hashimoto, K., Yoshida, H., Ishikawa, J. Wakao, H., Yoshimura, A., Kanakura, Y., Tomiyama, Y., Matsuzawa, Y. (1998) Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5. J. Biol. Chem. 273, 22877-22883.
17. Sandoval, C., Curtis, H., Congote, L. F. (2002) Enhanced proliferative effects of a baculovirus-produced fusion protein of insulin-like growth factor and alpha(1)-proteinase inhibitor and improved anti-elastase activity of the inhibitor with glutamate at position 351. Protein Eng. 15, 413-418.
18. Curtis, B. M., Williams, D. E., Broxmeyer, H. E., Dunn, J., Farrah, T., Jeffery, E., Clevenger, W., deRoos, P., Martin, U., Friend, D., Craig, V., Gayle, R., Price, V., Cosman, D., March, C. J., Park, L. S. (1991) Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein. Proc. Natl. Acad. Sci. USA 88, 5809-5813.
19. Vose, J. M., Anderson, J. E., Bierman, P. J., Appelbaum, F. R., Anderson, J. R., Garrison, L., Lebsack, M. E., Armitage, J. O. (1996) Phase I/II trial of PIXY321 to enhance engraftment following autologous bone marrow transplantation for lymphoid malignancy. J. Clin. Oncol. 14, 520-526.
20. Vadhan-Raj, S., Broxmeyer, H. E., Andreeff, M., Bandres, J. C., Buescher, E. S., Benjamin, R. S., Papadopoulos, N. E., Burgess, A., Patel, S., Plager, C., et al. (1995) In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I study. Blood 86, 2098-2105.
21. Lundell, B. I., Mandalam, R. K., Smith, A. K. (1999) Clinical scale expansion of cryopreserved small volume whole bone marrow aspirates produces sufficient cells for clinical use. J. Hematother. 8, 115-127.
22. Bachier, C. R., Gokmen, E., Teale, J., Lanzkron, S., Childs, C., Franklin, W., Shpall, E., Douville, J., Weber, S., Muller, T., Armstrong, D., LeMaistre, C. F. (1999) Ex-vivo expansion of bone marrow progenitor cells for hematopoietic reconstitution following high-dose chemotherapy for breast cancer. Exp. Hematol. 27, 615-623.
23. De Felice, L., Di Pucchio, T., Mascolo, M. G., Agostini, F., Breccia, M., Guglielmi, C., Ricciardi, M. R., Tafuri, A., Screnci, M., Mandelli, F., Arcese, W. (1999) Flt3LP3nduces the ex-vivo amplification of umbilical cord blood committed progenitors and early stem cells in short-term cultures. Br. J. Haematol. 106, 133-141.
24. Monahan, J. B., Hood, W. F., Welply, J. K., Shieb, J. J., Polazzi, J. O., Li, X. (2001) Bivalent binding and signaling characteristics of Leridistim, a novel chimeric dual agonist of interleukin-3 and granulocyte colony-stimulating factor receptors. Exp. Hematol. 29, 416-424.
25. Hood, W. F., Feng, Y. G., Schilling, R. J., Gokarn, Y., Jarvis, C., Remsen, E. E., Shieh, J. J., Joy, W., Klein, B. K., Polazzi, J. O., Welply, J. K., McKearn, J. P., Monahan, J. B. (2001) Modulation of the binding affinity of myelopoietins for the interleukin-3 receptor by the granulocyte colony-stimulating factor receptor agonist. Biochemistry 40, 13598-13606.
26. LeRoith, D., Werner, H., Beitner-Johnson, D., Roberts Jr., C. T. (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev. 16, 143-163.
27. Myers, M. G., Grammer, T. C., Wang, L. M., Sun, X. J., Pierce, J. H., Blenis, J., White, M. F. (1994) Insulin receptor substrate-1 mediates phosphatidylinositol 3′-kinase and p70S6k signaling during insulin, insulin-like growth factor-1, and interleukin-4 stimulation. J. Biol. Chem. 269, 28783-28789.
28. Songyang, Z., Baltimore, D., Cautley, L. C., Kaplan, D. R., Franke, T. F. (1997) Interleukin 3-dependent survival by the Akt protein kinase. Proc. Natl. Acad. Sci. USA 94, 11345-11350.
29. del Peso, L., Gonzalez-Garcia, M., Page, C., Herrera, R., Nunez, G. (1997) Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278, 687-689.
30. Zha, J., Harada, H., Yang, E., Jockel, J., Korsmeyer, S. J. (1996) Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 1.4-3-3 not BCL-X(L). Cell 87, 619-628.
31. Kinoshita, T., Shirouzu, M., Kamiya, A., Hashimoto, K., Yokoyama, S., Miyajima, A. (1997) Raf/MAPK and rapamycin-sensitive pathways mediate the anti-apoptotic function of p21Ras in IL-3-dependent hematopoietic cells. Oncogene 15, 619-627.
32. Sakai, I., Kraft, A. S. (1997) The kinase domain of Jak2 mediates induction of bcl-2 and delays cell death in hematopoietic cells. J. Biol. Chem. 272, 12350-12358.
33. Liu, C. B., Itoh, T., Arai, K., Watanabe, S. (1999) Constitutive activation of JAK2 confers murine interleukin-3-independent survival and proliferation of BA/F3 cells. J. Biol. Chem. 274, 6342-6349.
34. Silva, M., Grillot, D., Benito, A., Richard, C., Nunez, G., Fernandez-Luna, J. L. (1996) Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood 88, 1576-1582.
35. Leverrier, Y., Thomas, J., Perkins, G. R., Mangeney, M., Collins, M. K., Marvel, J. (1997) In bone marrow derived Baf-3 cells, inhibition of apoptosis by IL-3 is mediated by two independent pathways. Oncogene 14, 425-430.
36. Boise, L. H., Gonzalez-Garcia, M., Postema, C. E., Ding, L., Lindsten, T., Turka, L. A., Mao, X., Nunez, G., Thompson, C. B. (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597-608.
37. Socolovsky, M., Fallon, A. E., Wang, S., Brugnara, C., Lodish, H. F. (1999) Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/-mice: a direct role for Stat5 in Bel-X(L) induction. Cell 98, 181-191.
38. McCubrey, J. A., Steelman, L. S., Mayo, M. W., Algate, P. A., Dellow, R. A., Kaleko, M. (1991) Growth-promoting effects of insulin-like growth factor-1 (IGF-1) on hematopoietic cells: overexpression of introduced IGF-1 receptor abrogates interleukin-3 dependency of murine factor-dependent cells by a ligand-dependent mechanism. Blood 78, 921-929.
39. DiFalco, M. R., Congote, L. F. (2002) Potentiation of hematopoietic cell migration with an IGF-interleukin-3 fusion protein. FEBS Lett. 524, 149-153.
40. Freund, G. G., Kulas, D. T., Mooney, R. A. (1993) Insulin and IGF-1 increase mitogenesis and glucose metabolism in the multiple myeloma cell line, RPMI 8226. J. Immunol. 151, 1811-1820.
41. Gold, M. R., Duronio, V., Saxena, S. P., Schrader, J. W., Aebersold, R. (1994) Multiple cytokines activate phosphatidylinositol 3-kinase in hemopoietic cells. Association of the enzyme with various tyrosine-phosphorylated proteins. J. Biol. Chem. 269, 5403-5412.